December 18, 2001 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The $16 billion deal is the biggest merger of two biotech companies to date.
“This is clearly going to be the bellwether deal” for the biotech industry, said Latham & Watkins Partner Charles Nathan, who, along with Charles Ruck, led the 20-plus attorney team that represented Amgen. The team was tapped on the shoulder in August, said Nathan.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
